ADVENTRX Pharmaceuticals (ANX)
ADVENTRX Pharmaceuticals Times Interest Earned TTM: -1401
View ANX Times Interest Earned TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
ANX Times Interest Earned TTM Rankings
| Overall | 1st percentile | 3017 of 3051 |
| Sector | 4th percentile | 337 of 352 in Healthcare |
| Industry | 10th percentile | 87 of 97 in Biotechnology |
ANX Times Interest Earned TTM Range, Past 5 Years
| Minimum | -6592 | Mar 2010 |
| Maximum | 44656 | Dec 2011 |
| Average | 9059 |
About Times Interest Earned (TTM)
Also known as the "Interest Coverage Ratio."
Times interest earned is a key metric to determine the credit worthiness of a business. Essentially, the number represents how many times the last 12 months' EBIT (earnings before interest and taxes) would have covered the past 12 months' interest expenses.
This ratio works well when looking at manufacturing businesses, utilities, and certain service businesses. It should be used with care when analyzing financial service companies because their business models borrow differently from traditional manufacturing and service businesses.
Learn More
You may also be interested in these ANX related companies
ANX News
Bio amazing. $ROSG truly a run for the ages. Just holding my small bios $ABIO and $ANX. Be interesting to see if ASCO conference pops them.
about 3 days ago by GarethSoloway
about 3 days ago by GarethSoloway
ADVENTRX Pharmaceuticals to Sponsor & Present at the Martin Center's 2012 Sickle Cell Disease Conference
Apr 16, 8:00AM PR Newswire
Apr 16, 8:00AM PR Newswire
RT @VistaPResearch $ANX Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals; $3.50 Target Price http://stks.co/2zLU
about 67 days ago by StockCowboy
about 67 days ago by StockCowboy
Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price
Mar 21, 9:15AM PR Newswire
Mar 21, 9:15AM PR Newswire
@adamfeuerstein $ANX is ABSOLUTE GARBAGE ! All they do is print paper and pay out banking fees. Culley is a JOKE!!
about 73 days ago by Bullbear123
about 73 days ago by Bullbear123
@StockCowboy $ANX Probably won't have a repeat tomorrow. 150M shelf offering.
about 80 days ago by Random_Walk
about 80 days ago by Random_Walk
RT @GarethSoloway Nice day on $ANX. Market otherwise so quiet. Volume 71.5M. Nuts.
about 80 days ago by InTheMoneyStocks
about 80 days ago by InTheMoneyStocks
ADVENTRX Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference on February 14
Feb 07, 8:00AM PR Newswire
Feb 07, 8:00AM PR Newswire
Biotech Sector on the Upswing -- Dendreon and ADVENTRX Pharmaceuticals Looking Strong
Jan 31, 8:20AM Marketwire
Jan 31, 8:20AM Marketwire
Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price
Dec 15, 9:21AM Benzinga
Dec 15, 9:21AM Benzinga
ADVENTRX (ANX) Discusses ANX-188 Phase 3 Structure w/ FDA; Additional Info Needed for Finalization
Dec 01, 8:40AM Street Insider
Dec 01, 8:40AM Street Insider
Speculative Healthcare Companies IntelGenx and Adventrx Begin to Gain Ground
Nov 15, 8:16AM Marketwire
Nov 15, 8:16AM Marketwire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ANX | 0.535 | -0.01 | -0.93% | 25.53M |
| ANW | 5.27 | +0.01 | +0.19% | 243.63M |
| ANV | 27.47 | -0.20 | -0.72% | 2.463B |
| ASEI | 49.46 | +1.29 | +2.68% | 441.18M |
| ASCMA | 52.78 | +1.12 | +2.17% | 710.95M |
| ASCA | 18.42 | +0.13 | +0.71% | 605.47M |
| ASBC | 12.76 | -0.04 | -0.31% | 2.229B |
| ASA | 22.96 | +0.22 | +0.97% | |
| ARX | 6.54 | +0.01 | +0.15% | 554.72M |
| ARWRD | 4.120 | -0.05 | -1.20% |
